Get the latest tech news

Trial Shows a Single Dose of an Experimental Therapy Reduces Lipoprotein(a), an Important Heart Disease Risk Factor, More than 94% for Nearly a Year

None

Related news:

Exxon wants to drill enough lithium out of Arkansas to power 1M EVs per year

Meta engineer: Only two nuclear power plants needed to fuel AI inference next year

Call of Duty: Modern Warfare 3 UK boxed sales down 25% on last year